BR112021017738A2 - - Google Patents
Info
- Publication number
- BR112021017738A2 BR112021017738A2 BR112021017738A BR112021017738A BR112021017738A2 BR 112021017738 A2 BR112021017738 A2 BR 112021017738A2 BR 112021017738 A BR112021017738 A BR 112021017738A BR 112021017738 A BR112021017738 A BR 112021017738A BR 112021017738 A2 BR112021017738 A2 BR 112021017738A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/03—Compounds acting on the NO pathway, e.g. nitrososarginine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/231—Interleukin-10 (IL-10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19162270 | 2019-03-12 | ||
| PCT/EP2020/056625 WO2020182935A1 (en) | 2019-03-12 | 2020-03-12 | Immunomodulating mesenchymal stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112021017738A2 true BR112021017738A2 (US20030157025A1-20030821-C00031.png) | 2021-11-16 |
| BR112021017738A8 BR112021017738A8 (pt) | 2022-08-02 |
Family
ID=65801891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021017738A BR112021017738A8 (pt) | 2019-03-12 | 2020-03-12 | Células-tronco mesenquimais imunomoduladoras |
Country Status (9)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202320819A (zh) | 2021-07-08 | 2023-06-01 | 比利時商比利時百靈佳殷格翰動物醫藥公司 | 用於治療慢性齦口炎之間葉幹細胞 |
| US20230014549A1 (en) | 2021-07-08 | 2023-01-19 | Boehringer Ingelheim Veterinary Medicine Belgium | Mesenchymal stem cells for use in the treatment of chronic kidney disease |
| AU2022307748A1 (en) | 2021-07-08 | 2024-01-25 | Boehringer Ingelheim Veterinary Medicine Belgium | Mesenchymal stem cells for use in the treatment of osteoarthritis in animals |
| US20230014698A1 (en) | 2021-07-08 | 2023-01-19 | Boehringer Ingelheim Veterinary Medicine Belgium | Mesenchymal stem cells for use in the treatment of atopic dermatitis |
| WO2024033462A1 (en) | 2022-08-11 | 2024-02-15 | Boehringer Ingelheim Vetmedica Gmbh | Mesenchymal stem cells for use in the treatment of insect-bite hypersensitivity in equines |
| WO2024133886A1 (en) * | 2022-12-23 | 2024-06-27 | Boehringer Ingelheim Veterinary Medicine Belgium | Primed mesenchymal stem cells for use in the treatment of chronic kidney disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6328960B1 (en) | 1998-03-18 | 2001-12-11 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| CA2564679C (en) * | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| WO2012051210A2 (en) * | 2010-10-11 | 2012-04-19 | The Administrators Of The Tulane Educational Fund | Mesenchymal stem cells and related therapies |
| ITRM20110403A1 (it) * | 2011-07-28 | 2013-01-29 | Ospedale Pediatrico Bambino Gesu | Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori. |
| WO2017160986A1 (en) | 2016-03-16 | 2017-09-21 | Cell Medicine, Inc. | Mesenchymal stem cells with enhanced efficacy |
| WO2020160457A1 (en) * | 2019-01-31 | 2020-08-06 | Primegen Biotech, Llc | Treatment of atopic dermatitis using mesenchymal stem cells and immune modulation |
-
2020
- 2020-03-12 AU AU2020235912A patent/AU2020235912A1/en active Pending
- 2020-03-12 EP EP20708513.5A patent/EP3938494A1/en active Pending
- 2020-03-12 US US17/436,640 patent/US20220154147A1/en active Pending
- 2020-03-12 CN CN202080018981.6A patent/CN113677789A/zh active Pending
- 2020-03-12 CA CA3132414A patent/CA3132414A1/en active Pending
- 2020-03-12 KR KR1020217029168A patent/KR20210139259A/ko unknown
- 2020-03-12 WO PCT/EP2020/056625 patent/WO2020182935A1/en active Application Filing
- 2020-03-12 MX MX2021010739A patent/MX2021010739A/es unknown
- 2020-03-12 BR BR112021017738A patent/BR112021017738A8/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020182935A1 (en) | 2020-09-17 |
| MX2021010739A (es) | 2021-12-15 |
| CA3132414A1 (en) | 2020-09-17 |
| AU2020235912A1 (en) | 2021-10-07 |
| CN113677789A (zh) | 2021-11-19 |
| JP2022524764A (ja) | 2022-05-10 |
| KR20210139259A (ko) | 2021-11-22 |
| US20220154147A1 (en) | 2022-05-19 |
| BR112021017738A8 (pt) | 2022-08-02 |
| EP3938494A1 (en) | 2022-01-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: BOEHRINGER INGELHEIM VETERINARY MEDICINE BELGIUM (BE) |